Literature DB >> 12008116

Oxidative stress mediates cell surface expression of SS-A/Ro antigen on keratinocytes.

Jun Saegusa1, Seiji Kawano, Masahiro Koshiba, Nobuhide Hayashi, Hidekazu Kosaka, Yoko Funasaka, Shunichi Kumagai.   

Abstract

Exposure to ultraviolet radiation exacerbates the skin lesions of autoimmune diseases, and is known to induce cell surface expression of SS-A/Ro antigen on keratinocytes in vitro. Following up on recent reports on ultraviolet-B (UVB)-induced oxidative stress, we examined the role of oxidative stress in the surface expression of SS-A/Ro antigen on human keratinocytes. First, the exclusive induction by UVB irradiation of the 52-kDa protein (Ro52) but not of the 60-kDa protein (Ro60) of SS-A/Ro antigen was demonstrated by means of indirect immunofluorescence. The surface expression of Ro52 induced by UVB irradiation was concentration-dependently inhibited by N-acetyl-L-cysteine, an antioxidant. Furthermore, surface expression of Ro52 was similarly induced by diamide, a chemical oxidant. We next used Hoechst 33342 staining and the TUNEL assay to demonstrate that a low dose (20 mJ/cm(2)) of UVB did not induce apoptosis but induced the surface expression of Ro52. Moreover, zVAD-fmk, a pan-caspase inhibitor, did not inhibit UVB-induced surface expression of Ro52 even at a high dose (200 mJ/cm(2)) of UVB, which was sufficient to induce apoptosis in keratinocytes in the absence of zVAD-fmk. Taken together, we concluded that UVB-induced surface expression of Ro52 on keratinocytes is mediated by oxidative stress through a pathway other than apoptosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12008116     DOI: 10.1016/s0891-5849(02)00797-9

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  10 in total

1.  UVB induced oxidative stress in human keratinocytes and protective effect of antioxidant agents.

Authors:  Guang-Hui Jin; Yang Liu; Shun-Zi Jin; Xiao-Dong Liu; Shu-Zheng Liu
Journal:  Radiat Environ Biophys       Date:  2007-02-06       Impact factor: 1.925

Review 2.  A review of the role and clinical utility of anti-Ro52/TRIM21 in systemic autoimmunity.

Authors:  Adrian Y S Lee
Journal:  Rheumatol Int       Date:  2017-04-17       Impact factor: 2.631

3.  Autoantibodies from mice exposed to Libby amphibole asbestos bind SSA/Ro52-enriched apoptotic blebs of murine macrophages.

Authors:  David J Blake; Scott A Wetzel; Jean C Pfau
Journal:  Toxicology       Date:  2008-01-19       Impact factor: 4.221

4.  Different temporal expression of immunodominant Ro60/60 kDa-SSA and La/SSB apotopes.

Authors:  J H Reed; P J Neufing; M W Jackson; R M Clancy; P J Macardle; J P Buyon; T P Gordon
Journal:  Clin Exp Immunol       Date:  2007-04       Impact factor: 4.330

5.  Autoantigen TRIM21/Ro52 as a Possible Target for Treatment of Systemic Lupus Erythematosus.

Authors:  Ryusuke Yoshimi; Yoshiaki Ishigatsubo; Keiko Ozato
Journal:  Int J Rheumatol       Date:  2012-06-04

Review 6.  Managing Sjögren's Syndrome and non-Sjögren Syndrome dry eye with anti-inflammatory therapy.

Authors:  Terry G Coursey; Cintia S de Paiva
Journal:  Clin Ophthalmol       Date:  2014-08-04

Review 7.  TRIM21/Ro52 - Roles in Innate Immunity and Autoimmune Disease.

Authors:  Esther L Jones; Stephen M Laidlaw; Lynn B Dustin
Journal:  Front Immunol       Date:  2021-09-06       Impact factor: 7.561

Review 8.  Current concepts of photosensitivity in cutaneous lupus erythematosus.

Authors:  Benjamin Klein; Manfred Kunz
Journal:  Front Med (Lausanne)       Date:  2022-08-25

9.  IL-33/ST2 Activation Is involved in Ro60-Regulated Photosensitivity in Cutaneous Lupus Erythematosus.

Authors:  Yitian Song; Fangzhi Wei; Ying Liu; Feng Han; Lihui Ma; Yanping Zhuang; Chengdan Pan; Zhandong Jia; Aimin Gong
Journal:  Mediators Inflamm       Date:  2022-07-20       Impact factor: 4.529

Review 10.  Clinical and pathological roles of Ro/SSA autoantibody system.

Authors:  Ryusuke Yoshimi; Atsuhisa Ueda; Keiko Ozato; Yoshiaki Ishigatsubo
Journal:  Clin Dev Immunol       Date:  2012-12-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.